Agile Therapeutics
AGRX
₹129.20
Share price
0.00%
Change (1 day)
157.60%
Change (1 year)
Categories
Agile Therapeutics (AGRX) Fails to deliver data
Key failure to deliver metrics for Agile Therapeutics :
- Last SEC data release: 2025-02-28
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: N/A
- Last year FTD volume: N/A
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Agile Therapeutics (AGRX) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Agile Therapeutics (AGRX) - since 2023
Volume in USD (price x number of shares), data since 2023Agile Therapeutics (AGRX) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | ₹0.48 M | -50.63% |
| 2023 | ₹0.98 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 | ₹0.44 M | ₹0.62 M | 🇺🇸 USA |
 | N/A | ₹5.91 M | 🇺🇸 USA |
 | ₹17.52 M | ₹0.22 B | 🇺🇸 USA |
 | ₹0.10 B | ₹0.17 B | 🇺🇸 USA |
 | ₹29.94 M | ₹0.34 B | 🇺🇸 USA |